MRNA
MRNA
NASDAQ · Biotechnology

Moderna Inc

$59.35
-4.62 (-7.22%)
As of Jun 22, 9:41 PM ET ·
Day Range $57.50 — $65.51
52W Range $22.28 — $67.74

Performance

1D
1W
1M
3M
6M +90.21%
1Y +131.18%
YTD +92.30%
Open$64.07
Previous Close$63.96
Day High$65.51
Day Low$57.50
52W High$67.74
52W Low$22.28
Volume
Avg Volume8.66M
Market Cap25.38B
P/E Ratio
EPS$-8.15
SectorBiotechnology

Technical Indicators

Full analysis →
SMA 50 $37.98 Above
SMA 200 $29.64 Above
RSI (14) 57.2 Neutral
Trend Golden Cross Bullish

Analyst Ratings

Hold
30 analysts
4 Buy 19 Hold 7 Sell
Price Target +151.8% upside
Current
$59.35
Target
$149.45
$89.97 $149.45 avg $212.09

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 1.98B 4.26B 2.23B
Net Income -2,878,486,015 -5,564,083,791 -285,156,561
Profit Margin -145.2% -137.9% -12.8%
EBITDA -2,916,220,389 -5,950,191,944 -355,384,473
Free Cash Flow -237,052,091
Rev Growth -53.4% -53.4% +3.0%
Debt/Equity 0.07 0.07 0.52

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $230.01 +6.25% 105.2 382.49B
AMGN Amgen Inc $344.72 +2.11% 23.4 182.21B
GILD Gilead Sciences Inc $124.87 +0.90% 16.7 153.66B
VRTX Vertex Pharmaceuticals Inc $466.79 +3.36% 26.4 114.63B
REGN Regeneron Pharmaceuticals $612.50 +0.42% 14.5 63.95B
ALNY Alnylam Pharmaceuticals Inc $286.41 +2.99% 64.3 37.13B